You are here

Lobbying pays off drugmaker in bill

WASHINGTON (AP)  A provision tucked into the massive congressional budget bill will benefit a small pharmaceutical company in Washington state.

Lawmakers acted after a lobbying campaign by Omeros, which makes a drug for cataract surgery, and stepped-up political contributions from people associated with the company.

The provision props up the price Medicare pays for that drug, as well as a handful of products from other firms.

Aides said Rep. Cathy McMorris Rodgers of Washington, the fourth-ranking House Republican, took the issue to Speaker Paul Ryan, securing a place for the drug provision in the spending bill signed Friday by President Donald Trump.

The Lawton Constitution

102 SW 3rd, Lawton, OK
Classifieds: (580) 357-9545
Circulation: (580) 353-6397
Switchboard: (580) 353-0620